Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Genprex, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 38 | 39 | +1 |
| Shares | 3.83M | 6.61M | +2.77M (+72.3%) |
| Value | $3.64M | $2.61M | −$1.03M (−28.3%) |
New holders (6)
Institutions that held Genprex, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CVI Holdings, LLC | 1,968,050 | $777.2K | 1.54% |
| AMH Equity Ltd | 813,135 | $321.1K | 0.41% |
| Virtu Financial LLC | 61,305 | $24.0K | 0.00% |
| Confluence Wealth Services, Inc. | 21,295 | $8.41K | 0.00% |
| Two Sigma Securities, LLC | 17,951 | $7.09K | 0.00% |
| Citadel Advisors LLC | 10,828 | $4.28K | 0.00% |
Sold out (5)
Institutions that held Genprex, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Rockefeller Capital Management L.P. | 150,000 | $142.3K |
| CCG Wealth Management, LLC | 15,100 | $14.3K |
| HighTower Advisors, LLC | 12,078 | $12.0K |
| Tower Research Capital LLC (TRC) | 10,228 | $9.71K |
| Sofos Investments, Inc. | 1 | – |